PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30612458-4	2019	In vitro, LSE and its purified compound (-)-epigallocatechin (EGC) dose-dependently inhibited the expressions of pro-inflammatory cytokines and mediators, including tumor necrosis factor (TNF)- alpha , interleukin (IL)-6, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), without affecting cell viability in LPS-stimulated human hepatoma cell line HepG2.	gallocatechol	40-60	interleukin 6	Homo sapiens	202-220	
14997289-6	2004	The frequencies of the different IL-6 genotypes were 27.5% (GG), 47.9% (GC), 24.6% (CC).	gallocatechol	72-74	interleukin 6	Homo sapiens	33-37	
30612458-4	2019	In vitro, LSE and its purified compound (-)-epigallocatechin (EGC) dose-dependently inhibited the expressions of pro-inflammatory cytokines and mediators, including tumor necrosis factor (TNF)- alpha , interleukin (IL)-6, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), without affecting cell viability in LPS-stimulated human hepatoma cell line HepG2.	gallocatechol	62-65	interleukin 6	Homo sapiens	202-220	
27465323-2	2016	We described the clinical features of SLEAP, and discussed the feasibility of plasma exchange (PE) combined with glucocorticosteroids (GC) in short-term prognosis and possible mechanism in reducing serum inflammatory cytokine IL-6 and removing serum lipids.	gallocatechol	135-137	interleukin 6	Homo sapiens	226-230	
28532672-1	2017	In this study, we found that catechins found in green tea (EGCG, EGC, and EC) differentially interfere with the IL-1beta signaling pathway which regulates the expression of pro-inflammatory mediators (IL-6 and IL-8) and Cox-2 in primary human rheumatoid arthritis synovial fibroblasts (RASFs).	gallocatechol	59-62	interleukin 6	Homo sapiens	201-205	
28532672-2	2017	EGCG and EGC inhibited IL-6, IL-8, and MMP-2 production and selectively inhibited Cox-2 expression.	gallocatechol	0-3	interleukin 6	Homo sapiens	23-27	
26445552-13	2015	Homozygous IL-6 -174C/C genotype carriers required higher doses of opioids than GG or GC carriers.	gallocatechol	86-88	interleukin 6	Homo sapiens	11-15	
25384728-7	2015	In the T1DM group, IL6-174CC carriers showed higher concentrations of glycated hemoglobin (p = 0.029), albumin-to-creatinine ratio (p = 0.021), total cholesterol (p = 0.010), and LDL-cholesterol (p = 0.002), when compared with GG+GC carriers.	gallocatechol	230-232	interleukin 6	Homo sapiens	19-22